Core Insights - Kronos Worldwide reported a quarterly loss of $0.18 per share, significantly worse than the Zacks Consensus Estimate of a loss of $0.06, marking an earnings surprise of -200.00% [1] - The company's revenues for the quarter ended September 2025 were $456.9 million, missing the Zacks Consensus Estimate by 4.52% and down from $484.7 million a year ago [2] - Kronos Worldwide's stock has declined approximately 51.5% year-to-date, contrasting with a 15.6% gain in the S&P 500 [3] Financial Performance - Over the last four quarters, Kronos Worldwide has consistently failed to meet consensus EPS estimates [2] - The current consensus EPS estimate for the upcoming quarter is -$0.08 on revenues of $399.82 million, and for the current fiscal year, it is -$0.06 on revenues of $1.86 billion [7] Market Outlook - The company's earnings outlook is uncertain, and future stock performance will depend on management's commentary during the earnings call [3][4] - The Zacks Industry Rank places the Chemical - Diversified sector in the bottom 9% of over 250 Zacks industries, indicating potential challenges ahead [8] Estimate Revisions - The trend for estimate revisions for Kronos Worldwide was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market [6]

Core Insights - Avient reported quarterly earnings of $0.7 per share, exceeding the Zacks Consensus Estimate of $0.69 per share, and showing an increase from $0.65 per share a year ago, resulting in an earnings surprise of +1.45% [1] - The company posted revenues of $806.5 million for the quarter ended September 2025, which was below the Zacks Consensus Estimate by 1.82% and a decrease from $815.2 million year-over-year [2] - Avient has surpassed consensus EPS estimates in all four of the last quarters, but has only topped revenue estimates once in the same period [2] Earnings Outlook - The sustainability of Avient's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.54 on revenues of $758.03 million, and for the current fiscal year, it is $2.80 on revenues of $3.27 billion [7] Industry Context - The Chemical - Diversified industry, to which Avient belongs, is currently ranked in the bottom 8% of over 250 Zacks industries, indicating a challenging environment [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Avient's performance [5][6]

Company Performance - Kronos Worldwide reported a quarterly loss of $0.08 per share, missing the Zacks Consensus Estimate of $0.13, and down from earnings of $0.17 per share a year ago, representing an earnings surprise of -161.54% [1] - The company posted revenues of $494.4 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 1.32%, and down from $500.5 million in the same quarter last year [2] - Over the last four quarters, Kronos Worldwide has surpassed consensus EPS estimates only once and has topped consensus revenue estimates just once [2] Stock Performance - Kronos Worldwide shares have declined approximately 43.6% since the beginning of the year, contrasting with the S&P 500's gain of 7.1% [3] - The current Zacks Rank for Kronos Worldwide is 4 (Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.14 on revenues of $484.36 million, and for the current fiscal year, it is $0.53 on revenues of $1.9 billion [7] - The trend of estimate revisions for Kronos Worldwide was unfavorable prior to the earnings release, which may impact future stock movements [5][6] Industry Context - The Chemical - Diversified industry, to which Kronos Worldwide belongs, is currently ranked in the bottom 7% of over 250 Zacks industries, suggesting a challenging environment [8]

Company Performance - Eastman Chemical reported quarterly earnings of $1.6 per share, missing the Zacks Consensus Estimate of $1.72 per share, and down from $2.15 per share a year ago, representing an earnings surprise of -6.98% [1] - The company posted revenues of $2.29 billion for the quarter ended June 2025, which also missed the Zacks Consensus Estimate by 0.13%, and compared to year-ago revenues of $2.36 billion [2] - Over the last four quarters, Eastman Chemical has surpassed consensus EPS estimates three times, but has topped consensus revenue estimates only once [2] Stock Performance - Eastman Chemical shares have lost about 19.6% since the beginning of the year, while the S&P 500 has gained 8.2% [3] - The current status of estimate revisions for Eastman Chemical translates into a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] Future Outlook - The current consensus EPS estimate for the coming quarter is $1.83 on revenues of $2.41 billion, and for the current fiscal year, it is $7.16 on revenues of $9.25 billion [7] - The outlook for the industry, specifically the Chemical - Diversified sector, is currently in the bottom 6% of over 250 Zacks industries, which may materially impact the stock's performance [8]

Company Overview - Kronos Worldwide (KRO) is expected to report a year-over-year decline in earnings despite higher revenues for the quarter ended June 2025, with earnings projected at $0.13 per share, reflecting a -23.5% change from the previous year [3][12] - Revenues are anticipated to be $500.99 million, which is a slight increase of 0.1% compared to the same quarter last year [3] Earnings Estimates and Revisions - The consensus EPS estimate has been revised down by 51.86% over the last 30 days, indicating a significant reassessment by analysts [4] - The Most Accurate Estimate for Kronos Worldwide matches the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [12] Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, but its predictive power is significant primarily for positive readings [9][10] - Kronos Worldwide currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat [12] Historical Performance - In the last reported quarter, Kronos Worldwide was expected to post earnings of $0.17 per share but delivered only $0.16, resulting in a surprise of -5.88% [13] - Over the past four quarters, the company has only beaten consensus EPS estimates once [14] Industry Context - In comparison, DuPont de Nemours (DD), another player in the Zacks Chemical - Diversified industry, is expected to post earnings of $1.06 per share for the same quarter, indicating a year-over-year increase of +9.3% [18] - DuPont's revenues are projected to be $3.22 billion, up 1.4% from the previous year, with a lower Most Accurate Estimate leading to an Earnings ESP of -0.62% [19]

Core Viewpoint - Kronos Worldwide reported quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of $0.17 per share, but showing an improvement from $0.07 per share a year ago, indicating a mixed performance in earnings despite a revenue increase [1][2]. Financial Performance - The company posted revenues of $489.8 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 4.98% and showing an increase from $478.8 million year-over-year [2]. - Over the last four quarters, Kronos Worldwide has only surpassed consensus EPS estimates once [2]. Stock Performance - Shares of Kronos Worldwide have declined approximately 23.6% since the beginning of the year, contrasting with the S&P 500's decline of 4.7% [3]. - The current consensus EPS estimate for the upcoming quarter is $0.23 on revenues of $528.43 million, and for the current fiscal year, it is $0.90 on revenues of $2 billion [7]. Industry Outlook - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 24% of over 250 Zacks industries, suggesting that the industry outlook may negatively impact stock performance [8]. - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could influence investor sentiment [5].

Core Viewpoint - Air Products and Chemicals reported quarterly earnings of $2.69 per share, missing the Zacks Consensus Estimate of $2.84 per share, and down from $2.85 per share a year ago [1][2] Financial Performance - The company posted revenues of $2.92 billion for the quarter ended March 2025, missing the Zacks Consensus Estimate by 1.15%, and down from $2.93 billion year-over-year [3] - The earnings surprise for the quarter was -5.28%, and the company has not beaten consensus revenue estimates over the last four quarters [2][3] Stock Performance - Air Products and Chemicals shares have declined approximately 6.5% since the beginning of the year, compared to a decline of 5.3% for the S&P 500 [4] - The current Zacks Rank for the stock is 3 (Hold), indicating expected performance in line with the market in the near future [7] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $3.31 on revenues of $3.03 billion, and for the current fiscal year, it is $12.65 on revenues of $12.15 billion [8] - The estimate revisions trend for the company is mixed, and future earnings expectations will be influenced by management's commentary on the earnings call [5][6] Industry Context - The Chemical - Diversified industry, to which Air Products and Chemicals belongs, is currently in the bottom 17% of over 250 Zacks industries, indicating potential challenges ahead [9]